20 5月 2021 by admin in UncategorizedComments Crescendo Biologics announces initiation of Phase 1 study of CB307 in patients with advanced, PSMA-positive solid tumours
19 5月 2021 by admin in UncategorizedComments NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
19 5月 2021 by admin in UncategorizedComments Arcellx to Present Data from Phase 1 Study of CART-ddBCMA Demonstrating Continued Positive Response in Patients with Relapsed and Refractory Multiple Myeloma at the 2021 ASCO Annual Meeting
17 5月 2021 by admin in UncategorizedComments Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates
13 5月 2021 by admin in UncategorizedComments Preclinical Data of Arcellx’s Novel Synthetic CAR-T Binding Domain Presented at the 2021 ASGCT Annual Meeting and the 2021 PEGS Summit
12 5月 2021 by admin in UncategorizedComments Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
10 5月 2021 by admin in UncategorizedComments Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 5月 2021 by admin in UncategorizedComments Crescendo Biologics further strengthens leadership team with appointment of Dr Michael Booth as Chief Financial Officer
06 5月 2021 by admin in UncategorizedComments Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
